Literature DB >> 29363449

Genetic Diversity of the Plasmodium falciparum Glutamate-Rich Protein R2 Region Before and Twelve Years after Introduction of Artemisinin Combination Therapies among Febrile Children in Nigeria.

Christian N Nguetse1,2, Johnson Adeyemi Ojo3, Charles Nchotebah2, Moses Nkechukwu Ikegbunam4, Christian G Meyer5,2, Bolaji N Thomas6, Thirumalaisamy P Velavan2,5,7, Olusola Ojurongbe2,3.   

Abstract

The genetic diversity of glutamate-rich protein (GLURP) R2 region in Plasmodium falciparum isolates collected before and 12 years after the introduction of artemisinin combination treatment of malaria in Osogbo, Osun State, Nigeria, was compared in this study. Blood samples were collected on filter paper in 2004 and 2015 from febrile children from ages 1-12 years. The R2 region of the GLURP gene was genotyped using nested polymerase chain reaction and by nucleotide sequencing. In all, 12 GLURP alleles were observed in a total of 199 samples collected in the two study years. The multiplicity of infection (MOI) marginally increased over the two study years; however, the differences were statistically insignificant (2004 samples MOI = 1.23 versus 2015 samples MOI = 1.47). Some alleles were stable in their prevalence, whereas two GLURP alleles, VIII and XI, showed considerable variability between both years. This variability was replicated when GLURP sequences from other regions were compared with ours. The expected heterozygosity (He) values (He = 0.87) were identical for the two groups. High variability in the rearrangement of the amino acid repeat units in the R2 region were observed, with the amino acid repeat sequence DKNEKGQHEIVEVEEILPE more prevalent in both years, compared with the two other repeat sequences observed in the study. The parasite population characterized in this study displayed extensive genetic diversity. The detailed genetic profile of the GLURP R2 region has the potential to help guide further epidemiological studies aimed toward the rational design of novel chemotherapies that are antagonistic toward malaria.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29363449      PMCID: PMC5930894          DOI: 10.4269/ajtmh.17-0621

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  41 in total

1.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

2.  Statistical tests of neutrality of mutations.

Authors:  Y X Fu; W H Li
Journal:  Genetics       Date:  1993-03       Impact factor: 4.562

3.  Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.

Authors:  Ikhlaq Hussain Kana; Bright Adu; Régis Wendpayangde Tiendrebeogo; Susheel Kumar Singh; Daniel Dodoo; Michael Theisen
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

4.  A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; José Francisco Fernandes; Béatrice Peggy Abossolo; Barbara Gaelle Nfono Ondo Methogo; Anita Lumeka Kabwende; Ayola Akim Adegnika; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Sonia Machevo; Sozinho Acacio; Helder Bulo; Betuel Sigauque; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Rose Minja; Maxmillian Mpina; Saumu Ahmed; Ali Mohammed Ali; Ali Takadir Mtoro; Ali Said Hamad; Paul Mutani; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Biébo Bihoun; Issa Guiraud; Berenger Kaboré; Olivier Sombié; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Martina Oneko; Chris Odero; Kephas Otieno; Norbert Awino; Meredith McMorrow; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Nekoye Otsyula; Stacey Gondi; Allan Otieno; Victorine Owira; Esther Oguk; George Odongo; Jon Ben Woods; Bernhards Ogutu; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Charity Maingi; Trudie Lang; Ally Olotu; Philip Bejon; Kevin Marsh; Gabriel Mwambingu; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; David Dosoo; Isaac Asante; George Adjei; Evans Kwara; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Coline Mahende; Edwin Liheluka; Lincoln Malle; Martha Lemnge; Thor G Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Anima Sarfo; Alex Agyekum; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Rutendo Nkomo; Tapiwa Tembo; Gerald Tegha; Mercy Tsidya; Jane Kilembe; Chimwemwe Chawinga; W Ripley Ballou; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Aurélie Olivier; Johan Vekemans; Terrell Carter; David Kaslow; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2012-11-09       Impact factor: 91.245

Review 5.  Molecular epidemiology of malaria.

Authors:  David J Conway
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Authors:  Bright Adu; Mariama K Cherif; Samuel Bosomprah; Amidou Diarra; Fareed K N Arthur; Emmanuel K Dickson; Giampietro Corradin; David R Cavanagh; Michael Theisen; Sodiomon B Sirima; Issa Nebie; Daniel Dodoo
Journal:  Malar J       Date:  2016-02-27       Impact factor: 2.979

7.  Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon.

Authors:  Nicaise Tuikue Ndam; Leonardo K Basco; Vincent Foumane Ngane; Ahidjo Ayouba; Eitel Mpoudi Ngolle; Philippe Deloron; Martine Peeters; Rachida Tahar
Journal:  Malar J       Date:  2017-03-27       Impact factor: 2.979

8.  Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.

Authors:  Kavita Gandhi; Mahamadou A Thera; Drissa Coulibaly; Karim Traoré; Ando B Guindo; Amed Ouattara; Shannon Takala-Harrison; Andrea A Berry; Ogobara K Doumbo; Christopher V Plowe
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

9.  Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.

Authors:  Bo Huang; Qi Wang; Changsheng Deng; Jianhua Wang; Tao Yang; Shiguang Huang; Xin-Zhuan Su; Yajun Liu; Longhua Pan; Guoming Li; Di Li; Hongying Zhang; Afane Bacar; Kamal Said Abdallah; Rachad Attoumane; Ahamada M S A Mliva; Shaoqin Zheng; Qin Xu; Fangli Lu; Yezhi Guan; Jianping Song
Journal:  Malar J       Date:  2016-08-15       Impact factor: 2.979

10.  Genetic Diversity of Plasmodium falciparum Populations in Malaria Declining Areas of Sabah, East Malaysia.

Authors:  Mohd Ridzuan Mohd Abd Razak; Umi Rubiah Sastu; Nor Azrina Norahmad; Abass Abdul-Karim; Amirrudin Muhammad; Prem Kumar Muniandy; Jenarun Jelip; Christina Rundi; Mallika Imwong; Rose Nani Mudin; Noor Rain Abdullah
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

View more
  4 in total

1.  Genetic polymorphism of Plasmodium falciparum msp-1, msp-2 and glurp vaccine candidate genes in pre-artemisinin era clinical isolates from Lakhimpur district in Assam, Northeast India.

Authors:  Vinayagam Sathishkumar; Tulika Nirmolia; Dibya Ranjan Bhattacharyya; Saurav Jyoti Patgiri
Journal:  Access Microbiol       Date:  2022-04-25

2.  Malaria surveillance amongst pregnant women attending antenatal care in private hospitals in Onitsha metropolis, South Eastern Nigeria.

Authors:  Moses N Ikegbunam; Chibuzo Uba; Judith Flügge; Harrison Abone; Dorothy Ezeagwuna; Simeon Ushie; Charles Esimone
Journal:  Malariaworld J       Date:  2022-02-01

3.  Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces.

Authors:  Bui Van Long; Genevieve Allen; Melanie Brauny; Le Thi Kieu Linh; Srinivas Reddy Pallerla; Tran Thi Thu Huyen; Hoang Van Tong; Nguyen Linh Toan; Do Quyet; Ho Anh Son; Thirumalaisamy P Velavan
Journal:  Malar J       Date:  2020-12-31       Impact factor: 2.979

4.  CD209 and Not CD28 or STAT6 Polymorphism Mediates Clinical Malaria and Parasitemia among Children from Nigeria.

Authors:  Olanrewaju B Morenikeji; Jessica L Metelski; Megan E Hawkes; Anna L Capria; Brooke N Seamans; Catherine O Falade; Olusola Ojurongbe; Bolaji N Thomas
Journal:  Microorganisms       Date:  2020-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.